静脉注射免疫球蛋白
參考文獻

1 2  . Therapeutic Goods Administration (TGA). 2022-07-15  [2022-07-17]. （原始内容存档于2022-07-14）.
↑  . Therapeutic Goods Administration (TGA). 2022-06-21  [2023-04-10]. （原始内容存档于2023-04-10）.
↑  . Therapeutic Goods Administration (TGA). 2022-06-21  [2023-04-10]. （原始内容存档于2023-04-10）.
↑  . Health Canada. 2014-10-23  [2022-06-07]. （原始内容存档于2022-06-07）.
↑  . Health Canada. 2014-10-23  [2022-08-06]. （原始内容存档于2024-08-05）.
↑  . Health Canada. 2018-05-09  [2024-04-13]. （原始内容存档于2022-01-19）.
↑  . Health Canada. 2020 -10-14  [2024-04-17]. （原始内容存档于2024-04-17）.  请检查|date=中的日期值 (帮助)
↑  . European Medicines Agency (EMA). 2013-06-03  [2020-07-14]. （原始内容存档于2020-07-15）.
↑  . DailyMed.   [2021-06-09]. （原始内容存档于2021-06-09）.
↑  . DailyMed.   [2021-06-09]. （原始内容存档于2021-06-09）.
↑  . DailyMed.   [2021-06-09]. （原始内容存档于2021-06-09）.
↑  . DailyMed. 15 December 2023  [2024-03-03]. （原始内容存档于2024-03-03）.
1 2 3 4 5 6 7 8  . The American Society of Health-System Pharmacists.   [8 January 2017]. （原始内容存档于9 January 2017）.
1 2 3 4 5 6   69. British Medical Association. 2015: 867–71. ISBN 9780857111562.
↑  Etzioni A, Ochs HD. . Academic Press. 2014: 283–84. ISBN 9780124115545. （原始内容存档于2017-01-09） （英语）.
↑  World Health Organization. . Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
↑  World Health Organization. . Geneva: World Health Organization. 2021. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.
↑  Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C. . The Journal of Allergy and Clinical Immunology (Review). April 2006, 117 (4 Suppl): S525–S553. PMID 16580469. doi:10.1016/j.jaci.2006.01.015 .
↑  van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. . Journal of Clinical Immunology. May 2010, 30 (S1): S74–S78. PMC 2883091 . PMID 20396937. doi:10.1007/s10875-010-9407-4.
↑  Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Miller RG, Sladky JT, Stevens JC. . Neurology. September 2003, 61 (6): 736–740. PMID 14504313. S2CID 20577426. doi:10.1212/WNL.61.6.736 .
↑  Pondrom S. . The AJT Report. American Journal of Transplantation. October 2014, 14 (10): 2195–2196. PMID 25231064. S2CID 221433035. doi:10.1111/ajt.12995 .
↑  . www.pcori.org. 2024-05-09  [2024-07-11]. （原始内容存档于2024-06-30） （英语）.
1 2 3 4  . Dynamed.   [2015-11-23]. （原始内容存档于2015-12-08）.  含有連結內容需訂閱查看的頁面 (link)Template:Subscription or libraries
↑  Daw Z, Padmore R, Neurath D, Cober N, Tokessy M, Desjardins D, Olberg B, Tinmouth A, Giulivi A. . Transfusion. August 2008, 48 (8): 1598–1601. PMID 18466176. S2CID 6010463. doi:10.1111/j.1537-2995.2008.01721.x.
↑  Lassiter HA, Bibb KW, Bertolone SJ, Patel CC, Stroncek DF. . The American Journal of Pediatric Hematology/Oncology. February 1993, 15 (1): 120–123. PMID 8447553. doi:10.1097/00043426-199302000-00019.
↑  Sugita K, Eguchi M. . Journal of Pediatric Hematology/Oncology. January 2005, 27 (1): 7–10. PMID 15654271. doi:10.1097/01.mph.0000149239.68396.72.
↑  Stoevesandt J, Heitmann J, Goebeler M, Benoit S. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology. December 2020, 18 (12): 1394–1404. PMID 33373142. doi:10.1111/ddg.14310_g .
↑  Lichtiger B. . Current Issues in Transfusion Medicine (The University of Texas M. D. Anderson Cancer Center). April 1994, 3: 1–7  [2015-11-23]. （原始内容存档于5 March 2016）.
1 2 3 4  Skoda-Smith S, Torgerson TR, Ochs HD. . Therapeutics and Clinical Risk Management. February 2010, 6: 1–10. PMC 2817783 . PMID 20169031. doi:10.2147/tcrm.s4353 .
↑  Powell L.  (PDF). Primary Immune Foundation.   [24 November 2015]. （原始内容存档 (PDF)于2015-12-22）.
↑  Misbah S, Sturzenegger MH, Borte M, Shapiro RS, Wasserman RL, Berger M, Ochs HD. . Clinical and Experimental Immunology //www.ncbi.nlm.nih.gov/pmc/articles/PMC2801034 |PMC=缺少标题 (帮助). December 2009, 158 (Suppl 1): 51–59. PMC 2801034 . PMID 19883424. doi:10.1111/j.1365-2249.2009.04027.x .
↑  Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR. . The Journal of Infectious Diseases. January 2015, 211 (1): 80–90. PMC 4264590 . PMID 25030060. doi:10.1093/infdis/jiu396.
↑  . www.who.int.   [2023-05-23]. （原始内容存档于2023-05-07） （英语）.
↑  . Plasvacc USA. 2021-05-20  [2023-05-23]. （原始内容存档于2023-03-27） （美国英语）.
↑  Dias da Silva W, De Andrade SA, Megale ÂA, De Souza DA, Sant'Anna OA, Magnoli FC, Guidolin FR, Godoi KS, Saladini LY, Spencer PJ, Portaro FC. . Toxins. September 2022, 14 (9): 606. PMC 9503307 . PMID 36136544. doi:10.3390/toxins14090606 .
↑  Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV. . The Journal of Infectious Diseases. February 1999, 179 (Suppl 1): S218–S223. PMID 9988187. doi:10.1086/514294 .
↑  Gern JE. . Pediatrics. August 2002, 110 (2): 467–8  [2012-05-28]. doi:10.1542/peds.110.2.S1.467-b. （原始内容存档于2008-06-11）.
↑  Nimmerjahn F, Ravetch JV. . J. Exp. Med. January 2007, 204 (1): 11–5. PMC 2118416 . PMID 17227911. doi:10.1084/jem.20061788.
↑  Clynes R. . J. Clin. Invest. January 2005, 115 (1): 25–7. PMC 539209 . PMID 15630438. doi:10.1172/JCI23994.
↑  Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH. . Nat. Med. June 2006, 12 (6): 688–92. PMID 16715090. doi:10.1038/nm1416.
↑  Bayry J, Thirion M, Misra N;  et al. . Neurol. Sci. October 2003,. 24 Suppl 4: S217–21. PMID 14598046. doi:10.1007/s10072-003-0081-7.  引文格式1维护：显式使用等标签 (link)
↑  Janke AD, Yong VW. . Neurol. Res. April 2006, 28 (3): 270–4. PMID 16687052. doi:10.1179/016164106X98143.
↑  Laupland KB, Kirkpatrick AW, Delaney A. . Crit. Care Med. December 2007, 35 (12): 2686–92. PMID 18074465. doi:10.1097/01.CCM.0000295312.13466.1C.
↑  Ingraham C. . Washington Post. 2021-11-25  [2023-05-23]. ISSN 0190-8286. （原始内容存档于2023-07-02） （美国英语）.
↑   (PDF). American Association of Allergists and Immunologists.   [2015-11-23]. （原始内容存档 (PDF)于2016-03-05）.
↑  . European Medicines Agency (EMA). 2011-06-06  [2020-05-02]. （原始内容存档于2020-08-01）.  Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
↑  . U.S. Food and Drug Administration (FDA). 2018-03-15  [2020-05-03]. （原始内容存档于2020-04-01）.
↑  Pierce LR.  (PDF) (报告). Review Office Signatory Authority Tejashri Purohit-Sheth. U.S. Food and Drug Administration (FDA). 2018-03-14  [2018-03-20]. （原始内容存档 (PDF)于2018-03-20）.
↑  Berman K.  (PDF). IG Living: 28–32.   [2015-11-23]. （原始内容存档 (PDF)于2015-10-27）.
1 2   (PDF). Creative Ceutical & EU commission.   [7 December 2015]. （原始内容存档 (PDF)于2015-12-22）.
↑  . transfusion.com.au.   [2019-11-14]. （原始内容存档于2019-09-04） （英语）.
↑  Andrew Pollack. . New York Times. 2012-07-17  [2012-07-19]. （原始内容存档于2012-07-19）.  含有內容需登入查看的頁面 (link)
↑  . CBS News. 2012-07-17  [2012-07-19]. （原始内容存档于2012-07-19）.
↑  . （原始内容存档于2013-06-07）.
↑  . www.businesswire.com. 2020-05-20  [2020-05-28]. （原始内容存档于2020-06-21） （英语）.
↑  Boyer LV, Theodorou AA, Berg RA, Mallie J, Chávez-Méndez A, García-Ubbelohde W, Hardiman S, Alagón A. . The New England Journal of Medicine. May 2009, 360 (20): 2090–2098. PMID 19439743. doi:10.1056/NEJMoa0808455 .
↑  Williams DJ, Habib AG, Warrell DA. . Toxicon. August 2018, 150: 1–10. Bibcode:2018Txcn..150....1W. PMID 29746978. S2CID 13665273. doi:10.1016/j.toxicon.2018.05.001.